Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432-Reference-Cited by-同舟云学术

Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432

Published:1999-02 Issue:2 Volume:38 Page:223-231
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Chergui Karima,G. Lacey Michael

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference44 articles.

1. Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long-term potentiation through protein kinase C;Aniksztejn;Eur. J. Neurosci.,1992

2. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation;Birchall;J. Pharmacol. Exper. Ther.,1994

3. Inhibitors of protein kinase C (3): potent and highly selective bisindolylmaelimides by conformational restriction;Bit;J. Med. Chem.,1993

4. Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism;Blank;J. Neurosci. Res.,1996

5. The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-d-aspartate responses;Blank;Proc. Natl. Acad. Sci. USA,1997

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contingent Amygdala Inputs Trigger Heterosynaptic LTP at Hippocampus-To-Accumbens Synapses;The Journal of Neuroscience;2022-07-15

2. Ventral Tegmental Area Projection Regulates Glutamatergic Transmission in Nucleus Accumbens;Scientific Reports;2019-12

3. Dopamine induces release of calcium from internal stores in layer II lateral entorhinal cortex fan cells.;Cell Calcium;2019-06

4. Molecular and synaptic mechanisms regulating drug-associated memories: Towards a bidirectional treatment strategy;Brain Research Bulletin;2018-07

5. Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease;CNS Neuroscience & Therapeutics;2018-03-03